nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—L-Tyrosine—Melphalan—peripheral nervous system neoplasm	0.532	0.585	CrCrCtD
Mimosine—L-DOPA—Melphalan—peripheral nervous system neoplasm	0.377	0.415	CrCrCtD
Mimosine—TYR—Dopamine metabolism—TH—peripheral nervous system neoplasm	0.0197	0.247	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—LIN28B—peripheral nervous system neoplasm	0.00925	0.116	CbGpPWpGaD
Mimosine—L-Tyrosine—TH—peripheral nervous system neoplasm	0.00579	1	CrCbGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—NME1—peripheral nervous system neoplasm	0.00368	0.0463	CbGpPWpGaD
Mimosine—SHMT1—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00364	0.592	CbGdCrCtD
Mimosine—CCL2—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.00351	0.0441	CbGpPWpGaD
Mimosine—SHMT1—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00251	0.408	CbGdCrCtD
Mimosine—CCL2—Ectoderm Differentiation—NF2—peripheral nervous system neoplasm	0.0024	0.0301	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—SLC2A1—peripheral nervous system neoplasm	0.00188	0.0236	CbGpPWpGaD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.00174	0.0218	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.00169	0.0212	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—PTPN11—peripheral nervous system neoplasm	0.00159	0.02	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00158	0.0198	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—peripheral nervous system neoplasm	0.00132	0.0166	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—BIRC5—peripheral nervous system neoplasm	0.00131	0.0164	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00116	0.0146	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00106	0.0133	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.00103	0.013	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00102	0.0128	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—NRAS—peripheral nervous system neoplasm	0.000959	0.012	CbGpPWpGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.000924	0.0116	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.000905	0.0114	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000806	0.0101	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000791	0.00994	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000773	0.00971	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.000729	0.00916	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000722	0.00907	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.000709	0.00891	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—HRAS—peripheral nervous system neoplasm	0.000701	0.00881	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.000588	0.00738	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00056	0.00703	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000557	0.007	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.000552	0.00694	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000536	0.00674	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000488	0.00613	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.000483	0.00606	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000475	0.00597	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—TP53—peripheral nervous system neoplasm	0.000467	0.00587	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.000463	0.00581	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000462	0.0058	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000452	0.00568	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—AKT1—peripheral nervous system neoplasm	0.000451	0.00567	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000447	0.00562	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.00044	0.00553	CbGpPWpGaD
Mimosine—SHMT1—Disease—GNS—peripheral nervous system neoplasm	0.000421	0.00529	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000414	0.0052	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000396	0.00498	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000395	0.00496	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000362	0.00455	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000353	0.00444	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GNS—peripheral nervous system neoplasm	0.000353	0.00443	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000338	0.00425	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NME1—peripheral nervous system neoplasm	0.000338	0.00425	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—COX2—peripheral nervous system neoplasm	0.000325	0.00409	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000317	0.00398	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000313	0.00394	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	0.000312	0.00391	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000299	0.00375	CbGpPWpGaD
Mimosine—SHMT1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000294	0.0037	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.00029	0.00365	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.00029	0.00364	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000289	0.00363	CbGpPWpGaD
Mimosine—SHMT1—Disease—ENO2—peripheral nervous system neoplasm	0.000255	0.0032	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000244	0.00307	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000234	0.00294	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000214	0.00268	CbGpPWpGaD
Mimosine—SHMT1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000206	0.00258	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000186	0.00233	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000185	0.00233	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—BCHE—peripheral nervous system neoplasm	0.00018	0.00227	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000172	0.00216	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000171	0.00215	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TH—peripheral nervous system neoplasm	0.00017	0.00213	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000162	0.00204	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000139	0.00174	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000136	0.00171	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000128	0.00161	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTPN11—peripheral nervous system neoplasm	0.000115	0.00144	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000113	0.00142	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00011	0.00138	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000105	0.00131	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.6e-05	0.00121	CbGpPWpGaD
Mimosine—SHMT1—Disease—ERBB2—peripheral nervous system neoplasm	9.09e-05	0.00114	CbGpPWpGaD
Mimosine—SHMT1—Disease—NRAS—peripheral nervous system neoplasm	6.91e-05	0.000868	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.79e-05	0.000853	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.67e-05	0.000838	CbGpPWpGaD
Mimosine—SHMT1—Disease—MYC—peripheral nervous system neoplasm	6.44e-05	0.000809	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.27e-05	0.000662	CbGpPWpGaD
Mimosine—SHMT1—Disease—HRAS—peripheral nervous system neoplasm	5.06e-05	0.000635	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.97e-05	0.000624	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.79e-05	0.000601	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT1—peripheral nervous system neoplasm	4.47e-05	0.000561	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.39e-05	0.000551	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.01e-05	0.000504	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKT1—peripheral nervous system neoplasm	3.74e-05	0.00047	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.74e-05	0.000469	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.07e-05	0.000385	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.93e-05	0.000369	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.59e-05	0.000325	CbGpPWpGaD
